日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.

TROP2 抗体-药物偶联物 Datopotamab Deruxtecan 在患者来源的乳腺癌异种移植模型中的抗肿瘤活性和生物标志物分析

Meric-Bernstam Funda, Yuca Erkan, Evans Kurt W, Zhao Ming, Maejima Takanori, Karibe Tsuyoshi, Raso Maria Gabriela, Tang Ximing, Zheng Xiaofeng, Rizvi Yasmeen Qamar, Akcakanat Argun, Scott Stephen M, Wang Bailiang, Byers Lauren A, Tripathy Debu, Okajima Daisuke, Damodaran Senthil

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

ATR激酶抑制剂Elimusertib单药或联合治疗对具有DNA损伤反应通路和其他基因组改变的肿瘤的疗效

Varadarajan Kaushik, Cruz Pico Christian X, Evans Kurt W, Raso Maria Gabriela, Rizvi Yasmeen Qamar, Zheng Xiaofeng, Chachad Dhruv, DiPeri Timothy P, Wang Bailiang, Scott Stephen M, Zhao Ming, Akcakanat Argun, Wengner Antje M, Yap Timothy A, Meric-Bernstam Funda

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

新型双特异性抗HER2抗体Zanidatamab在患者来源异种移植模型中的联合临床试验

DiPeri, Timothy P; Evans, Kurt W; Wang, Bailiang; Zhao, Ming; Akcakanat, Argun; Raso, Maria Gabriela; Rizvi, Yasmeen Q; Zheng, Xiaofeng; Korkut, Anil; Varadarajan, Kaushik; Uzunparmak, Burak; Dumbrava, Ecaterina E; Pant, Shubham; Ajani, Jaffer A; Pohlmann, Paula R; Jensen, V Behrana; Javle, Milind; Rodon, Jordi; Meric-Bernstam, Funda

Heterogeneous Profile of ROR1 Protein Expression across Tumor Types

不同肿瘤类型中 ROR1 蛋白表达的异质性

Maria Gabriela Raso, Elizve Barrientos Toro, Kurt Evans, Yasmeen Rizvi, Rossana Lazcano, Argun Akcakanat, Patrizia Sini, Francesca Trapani, Eva Johanna Madlener, Lorenz Waldmeier, Alexander Lazar, Funda Meric-Bernstam

Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy

利用液体活检进行口腔鳞状细胞癌诊断的策略方法

Kinane, Denis F; Gabert, Joerg; Xynopoulos, George; Guzeldemir-Akcakanat, Esra

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

表观遗传上调 TROP2 和 SLFN11 可增强 TROP2 抗体药物偶联物 sacitizumab govitecan 的治疗效果

Ming Zhao, Timothy P DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W Evans, Fei Yang, Argun Akcakanat, Marco Roberto Estecio, Debu Tripathy, Ecaterina E Dumbrava, Senthil Damodaran, Funda Meric-Bernstam

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

不可逆成纤维细胞生长因子受体抑制剂富巴替尼在FGFR改变的乳腺癌中的疗效

Turcin Saridogan ,Argun Akcakanat ,Ming Zhao ,Kurt W Evans ,Erkan Yuca ,Stephen Scott ,Bryce P Kirby ,Xiaofeng Zheng ,Min Jin Ha ,Huiqin Chen ,Patrick K S Ng ,Timothy P DiPeri ,Gordon B Mills ,Jordi Rodon Ahnert ,Senthil Damodaran ,Funda Meric-Bernstam

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

MEK/MDM2 联合抑制对 TP53 野生型甲状腺癌和伴有 MAPK 变异的结肠直肠癌具有抗肿瘤功效

Seyed Pairawan, Argun Akcakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen, Min Jin Ha, Yasmeen Rizvi, Vijaykumar Holla, Jing Wang, Kurt W Evans, Ming Zhao, Naifa Busaidy, Bingliang Fang, Jack A Roth, Ecaterina Ileana Dumbrava, Funda Meric-Bernstam

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

氧化磷酸化是化疗耐药性三阴性乳腺癌的代谢弱点

Kurt W Evans, Erkan Yuca, Stephen S Scott, Ming Zhao, Natalia Paez Arango, Christian X Cruz Pico, Turcin Saridogan, Maryam Shariati, Caleb A Class, Christopher A Bristow, Christopher P Vellano, Xiaofeng Zheng, Ana Maria Gonzalez-Angulo, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akcakanat, Bora Lim, D

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

转移性乳腺癌的基因组、转录组和蛋白质组分析

Akcakanat, Argun; Zheng, Xiaofeng; Cruz Pico, Christian X; Kim, Tae-Beom; Chen, Ken; Korkut, Anil; Sahin, Aysegul; Holla, Vijaykumar; Tarco, Emily; Singh, Gopal; Damodaran, Senthil; Mills, Gordon B; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda